Future licensees:
1)Laboratory Corp. of America Holdings(LH)
BUSINESS SUMMARY
Laboratory Corporation of America Holdings, together with its subsidiaries, operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease, as well as specialty testing services. Its routine tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, HIV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. Laboratory Corporation's specialty tests and related services comprise viral load testing, and HIV genotyping and phenotyping for infectious diseases; cytogenetic, molecular cytogenetic, biochemical, and molecular genetic tests for diagnostic genetics; oncology testing; clinical trials testing for pharmaceutical companies, which conducts clinical research trials on new drugs; forensic identity testing used in criminal proceedings and parentage evaluation services; allergy testing consisting of a range of allergen testing services, computerized analysis, and treatment program that enables primary care physicians to diagnose and treat various allergic disorders; and occupational testing services, which include urine and blood testing services for the detection of drug and alcohol abuse for private and government customers. The company's customers comprise physicians, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. As of December 31, 2007, it operated 37 primary laboratories and approximately 1,600 patient service centers
2)Quest Diagnostics Inc.(DGX)
BUSINESS SUMMARY
Quest Diagnostics Incorporated, together with its subsidiaries, provides diagnostic testing, information, and services in the United States. The company offers routine tests, including blood chemistries, blood cholesterol levels, complete blood cell counts, urinalyses, pregnancy and other prenatal tests, alcohol and other substance-abuse tests, and allergy tests. It also provides anatomic pathology services, including dermatopathology and other cancer diagnostic testing; and gene-based testing and other esoteric testing. In addition, Quest Diagnostics provides central laboratory testing performed in connection with clinical research trials on new drugs and vaccines; and risk assessment services for the life insurance industry. Further, the company manufactures and markets diagnostic test kits and specialized point-of-care testing for the professional market. Quest Diagnostics offers a range of clinical laboratory testing services to patients, physicians, hospitals, healthcare insurers, employers, governmental institutions, and other commercial clinical laboratories. As of December 31, 2007, it operated a network of approximately 2,100 patient service centers and principal laboratories, as well as approximately 150 smaller laboratories
3)Genomic Health Inc.(GHDX)
BUSINESS SUMMARY
Genomic Health, Inc., a life science company, engages in the development and commercialization of genomic-based clinical diagnostic tests for cancer in the United States. Its clinical diagnostic tests for cancer enable physicians and patients to make individualized treatment decisions. The company's genomic test, Oncotype DX, is a clinical laboratory test that predicts the likelihood of cancer recurrence, the likelihood of patient survival within 10 years of diagnosis, and the likelihood of chemotherapy benefit. This test is focused on patients with early stage, node negative, or N−, and estrogen receptor positive, or ER+, breast cancer. Genomic Health is in the early development phase of investigating additional genes and gene combinations that may add to the predictive power of Oncotype DX; and in the early development phase for a product to predict the likelihood of recurrence and chemotherapy benefit in N− and ER− breast cancer patients, as well as taxane benefit. In addition, the company has products in various stages of development for other cancers, including colon cancer, prostate cancer, renal cell cancer, non-small cell lung cancer, and melanoma. Further, it is in the early development phase to develop tests to predict the likelihood of response to the EGFR inhibitor class of drugs. Genomic Health has a collaborative agreement with Aventis, Inc. to investigate the ability of gene expression in fixed-paraffin-embedded tissues to predict the likelihood of response to adjuvant chemotherapy, including Taxotere, in patients with early breast cancer and zero to three involved lymph nodes.
4)Becton, Dickinson and Company(BDX)
BUSINESS SUMMARY
The company's BD Diagnostics segment provides products for the safe collection and transport of diagnostic specimens and instruments for analysis, including preanalytical and diagnostic systems comprising integrated systems for specimen collection, a line of safety-engineered blood collection products and systems, plated media, automated blood culturing systems, molecular testing systems for sexually transmitted diseases and healthcare-associated infections, microorganism identification and drug susceptibility systems, liquid-based cytology systems for cervical cancer screening, and rapid diagnostic assays. Its BD Biosciences segment offers fluorescence activated cell sorters and analyzers, cell imaging systems, monoclonal antibodies and kits for performing cell analysis, reagent systems for life sciences research, tools to aid in drug discovery and growth of living cells and tissue, cell culture media supplements for biopharmaceutical manufacturing, and diagnostic assays. Becton, Dickinson and Company serves hospitals, laboratories, clinics, consumers and retail pharmacies, public health agencies, pharmaceutical and biotech companies, healthcare workers, blood banks, patients, physicians' office practices, and academic and government institutions.
5)Roche(RHHBY)
Business Summary
Roche Holding is a pharmaceuticals and a diagnostics company which is based in Switzerland. Co.'s products and services cover every stage of the healthcare process, from identifying disease susceptibilities and testing for disease in at-risk populations to prevention, diagnosis, therapy and treatment monitoring. Co.'s operations are organized along two divisions: Pharmaceuticals and Diagnostics. Within the Pharmaceuticals Division there are three sub-divisions: Roche Pharmaceuticals, Genentech and Chugai. Co.'s Diagnostics Division offers a range of products and services in various fields of medical testing
6)Siemans(SI)Gold's favorite
BUSINESS SUMMARY
Siemens' Medical Solutions business offers diagnostic and therapeutic systems, devices, and consumables; and information technology systems.
